La Jolla Pharmaceutical Company (LJPC) Income Annual - Discounting Cash Flows
LJPC
La Jolla Pharmaceutical Company
LJPC (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2003
12-31
2002
12-31
2001
12-31
2000
12-31
1999
12-31
1998
12-31
1997
12-31
1996
12-31
1995
12-31
1994
12-31
Report Filing 2022-08-15 2022-03-09 2021-03-08 2020-03-02 2019-03-04 2018-02-22 2017-02-23 2016-02-25 2015-03-16 2014-03-31 2013-04-01 2012-03-30 2011-04-14 2010-04-15 2009-03-31 2008-03-17 2007-03-16 2006-03-13 2005-03-10 2004-03-15 2003-03-28 2002-03-28 2001-03-30 2000-02-25 1999-03-31 1998-03-30 1997-03-31 1995-12-31 1994-12-31
Revenue 46.49 75.72 33.42 23.05 10.06 0 0.616 1.06 0 0 0 0 0 8.12 0 55.11 35.76 35.76 0 0 0 0 0.001 4.69 8.6 9.9 4 3 0.6
Cost of Revenue 8.86 13.49 7.82 2.39 1.64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.381 -0.357 -0.4 -0.8 -0.8 -0.8 -0.7
Gross Profit 37.63 62.23 25.6 20.66 8.41 0 0.616 1.06 0 0 0 0 0 8.12 0 55.11 35.76 35.76 0 0 0 0 0.382 5.05 9 10.7 4.8 3.8 1.3
Operating Expenses 40.2 40.4 61.44 130.5 202.5 115.4 78.99 43.03 21.34 17.94 10.74 2.27 3.93 16.77 63.54 110.8 77.98 63.76 40.74 39.29 44.64 27.5 16.02 14.99 18.1 18.4 15.4 13 11.2
Research & Development 2.52 5.01 23.01 85.33 117.3 84.58 62.29 29.09 9.94 4.36 1.35 0.177 0.013 9.58 51.02 46.63 32.94 22.6 33.17 32.38 37.7 23.23 12.93 11.69 14.6 14.7 11.7 9.8 8.5
Selling, General and Administrative 37.67 35.39 38.43 45.13 85.16 30.85 16.7 13.93 11.4 13.58 9.39 2.1 3.92 7.19 9.7 9.06 9.29 5.41 7.57 6.91 6.94 4.27 2.71 2.94 3.1 2.9 2.9 2.4 2
Other Operating Expenses 0.006 0 0 0 0 0 0 0 0 0 0 0 0 0 2.81 55.11 35.76 35.76 0 0 0 0 0.381 0.357 0.4 0.8 0.8 0.8 0.7
Operating Income -2.57 21.83 -35.84 -109.8 -194.1 -115.4 -78.37 -41.97 -21.34 -17.94 -10.74 -2.27 -3.93 -8.64 -63.54 -55.69 -42.23 -28 -40.74 -39.29 -44.64 -27.5 -15.64 -9.94 -9.1 -7.7 -10.6 -9.2 -9.9
Net Non-Operating Interest -9.95 -10.45 -9.82 -8.65 -5.42 0 0 0 0 0 0 0 0 -0.013 0.683 0 0 0 0.573 0.875 1.42 2.87 0 0 0 0 0 0 0
Interest Income 0.005 0.007 0.235 2.13 1.89 0 0 0 0 0 0 0 0 0 0.779 0 0 0 0.383 0.665 1.37 2.84 0 0 0 0 0 0 0
Interest Expense 9.95 10.46 10.05 10.77 7.3 0 0 0 0 0 0 0 0 0.013 0.096 0 0 0 -0.19 -0.21 -0.051 -0.03 0 0 0 0 0 0 0
Equity & Other Income/(Expense) 16.54 8.33 6.23 1.94 0 0.624 0.187 0.057 0.027 0.004 3 -9.39 0.168 0.023 0 2.62 14.86 0.64 -0.38 -0.42 -0.102 -0.06 15.64 9.94 1.2 1.4 1.2 0.9 9.9
Income Before Tax 4.02 19.71 -39.42 -116.5 -199.5 -114.8 -78.19 -41.91 -21.31 -17.93 -7.74 -11.67 -3.76 -8.63 -62.85 -53.08 -27.36 -27.36 -40.54 -38.84 -43.32 -24.68 0 0 -7.9 -6.3 -9.4 -8.3 0
Income Tax Expense 2.5 0.049 0 0 1.89 0.624 0.187 0.057 0.027 0.004 0 0 0 0.036 0 0 14.86 0 0.193 0 0 0 0 0 0 1.4 1.2 0.9 0
Income Attributable to Non-Controlling Interest 0 0 0 0 -1.89 -0.624 -0.187 -0.057 -0.027 -0.004 0 -0.119 0 -0.036 0 0 -14.86 0 -0.193 0 0 0 13.8 9.15 0 -1.3 -1 -0.6 10.3
Net Income 1.52 19.66 -39.42 -116.5 -199.5 -114.8 -78.19 -41.91 -21.31 -17.93 -7.74 -11.55 -3.76 -8.63 -62.85 -53.08 -27.36 -27.36 -40.54 -38.84 -43.32 -24.68 -13.8 -9.15 -7.9 -6.4 -9.6 -8.6 -10.3
Depreciation and Amortization 1.79 1.88 4.08 4.55 4.41 1.27 0.73 0.347 0.017 0.005 3 -9.27 0.168 0.117 0.99 1.69 1.99 2.11 2.08 1.92 1.39 0.684 0.381 0.357 0.4 0.8 0.8 0.8 0.7
EBITDA -0.777 23.71 -31.75 -105.2 -189.6 -114.2 -77.64 -41.62 -21.32 -17.93 -7.74 -11.55 -3.76 -8.53 -62.55 -54.01 -40.24 -25.89 -38.65 -37.38 -43.25 -26.81 -15.26 -9.58 -8.7 -6.9 -9.8 -8.4 -9.2
Earnings Per Share (EPS) 0.043 0.58 -1.44 -4.3 -7.85 -5.41 -4.54 -2.68 -2 -39.48 -37.94 -1,565 -19,894 -65,908 -566,252 -671,848 -606,846 -420,969 -1,621,760 -1,941,900 -2,707,375 -1,763,071 -1,254,455 -1,143,625 -987,500 -914,286 -1,600,000 -1,720,000 -3,433,333
Diluted Earnings Per Share 0.043 0.58 -1.44 -4.3 -7.85 -5.41 -4.54 -2.68 -2 -39.48 -37.94 -1,565 -19,894 -65,908 -566,252 -671,848 -606,846 -420,969 -1,621,760 -1,941,900 -2,707,375 -1,763,071 -1,254,455 -1,143,625 -987,500 -914,286 -1,600,000 -1,720,000 -3,433,333
Weighted Average Shares Outstanding 32.08 34.18 27.33 27.11 25.42 21.21 17.23 15.65 10.67 0.454 0.204 0.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Diluted Weighted Average Shares Outstanding 32.08 34.18 27.33 27.11 25.42 21.21 17.23 15.65 10.67 0.454 0.204 0.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program